“IT’S BEGINNING TO LOOK A LOT LIKE…CONSPIRACY”
The GRINCH DEFENDANTS want to THROW OUT your ZANTAC CLIENT CASES!
LEARN HOW TO PROTECT YOUR ZANTAC CLIENTS NOW.
WHITEBOARD WEDNESDAY ON DECEMBER 16TH IS AN ABSOLUTE MUST FOR YOUR ZANTAC/RANITIDINE CASES.
With over 50,000 Zantac/Ranitidine cases and growing, the GRINCH DEFENDANTS are worried. They know this will be a massive MDL and they want to throw out as many cases as possible initially!
The DEFENDANTS will be actively attempting to have your Plaintiff’s cases thrown out by claiming that they have ceased marketing that particular Zantac/Ranitidine product based on their “end marketing” dates.
Go on a “SLAY RIDE” with John Ray and learn HOW TO COUNTER THIS DEFENDANT TACTIC AND SAVE YOUR CASES. Sign up for Whiteboard Wednesday on 12/16 (2PM-4PM EST).
Mass Tort Nexus has unraveled and uncovered a far-reaching CONSPIRACY (and identified the major conspirators) that produced, packaged, distributed and sold approximately 1,000 various Ranitidine products by employing a scheme involving obtaining multiple National Drug Code’s (NDC), for finished products with branding and labeling that was never approved by the FDA and for that matter, could not be approved by the FDA. Per (21 CFR §207.37 (a)(2)
SUM AND SUBTANCE. THRU THE MANIPULATION OF NDC CODES, COUNTERFEIT GENERIC “BRANDS” WERE PRODUCED AND SOLD BY THE GRINCH DEFENDANTS WITHOUT FDA APPROVAL.
ONCE YOU UNDERSTAND THE LAWS/REGULATIONS SURROUNDING THIS, YOU WILL BE ARMED TO IDENTIFY A COUNTERFEIT RANITIDINE PRODUCT IN VIOLATION OF 21 U.S. Code § 331. THRU REVIEW OF THE SPL (STRUCTED PRODUCT LABELING) INFORMATION AND OTHER EVIDENCE IN OUR POSESSION. WITH THIS INTELLIGENCE, YOU WILL BE READY TO DISCREDIT ANY AVERMENTS OF THESE GRINCH DEFENDANTS CLAIMING THAT THEY HAD CEASED “END” MARKETING A GIVEN PRODUCT AT THE TIME YOUR CLIENT CLAIMS TO HAVE PURCHASED IT.
ALL of this ground-breaking information will be discussed in further detail on the Zantac/Ranitidine Whiteboard Wednesday (2PM-4PM EST).
WE ARE ALMOST “MAX’ED” OUT- ONLY A FEW SPACES LEFT.